In terms of Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shree Ganesh Bio-Tech (India) has informed that the Company has fixed Friday, February 11, 2022 as the ‘Record Date’, for the purpose of sub- division of Company's 1 equity shares of face value of Rs 10 each into 10 equity shares of face value of Rs 1 each, subject to the approval of shareholders which is being obtained through Postal Ballot (including e-voting) in accordance with the applicable laws and regulations.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Venkys India | 1589.25 |
| Mangalam Global Ent | 12.93 |
| Kaveri Seed | 924.50 |
| Regaal Resources | 85.04 |
| Simran Farms | 165.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: